Michael J. LaBarre - 17 Oct 2023 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Signature
/s/ James R. Oehler, Attorney-in-Fact
Issuer symbol
HALO
Transactions as of
17 Oct 2023
Net transactions value
-$165,400
Form type
4
Filing time
17 Oct 2023, 19:28:14 UTC
Previous filing
19 Sep 2023
Next filing
16 Nov 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Options Exercise $199,800 +10,000 +6.6% $19.98 161,911 17 Oct 2023 Direct F1
transaction HALO Common Stock Sale $365,200 -10,000 -6.2% $36.52 151,911 17 Oct 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Option to Purchase Common Stock Options Exercise $0 -10,000 -20% $0.000000 41,099 17 Oct 2023 Common Stock 10,000 $19.98 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The option exercise and sale reported on this Form 4 were effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2022.
F2 This option was granted on February 10, 2020 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter.